Favipiravir is given for 14 days after study initiation.

2 trials

Sponsors

National Center for Global Health and Medicine

Conditions

Ebola virus disease

Unknown Phase

Investigation on the efficacy and safety of favipiravir in patients who are infected or strongly suspected of being infected with Ebola virus

Active, not recruitingJPRN-UMIN000016101

National Center for Global Health and MedicineEbola virus disease

Start: 2015-01-19Target: 5Updated: 2026-06-29

Investigation on the effect of favipiravir in preventing Ebola virus disease and its safety

Active, not recruitingJPRN-UMIN000016102

National Center for Global Health and MedicineEbola virus disease

Start: 2015-01-19Target: 25Updated: 2026-06-29